Volvo Cars, the premium carmaker, will bring a new standard of safety and user experience to the small SUV premium segment with the launch of the new Volvo XC40 this autumn.
Developed around the challenges of modern city life, the XC40 aims to make the daily urban commute less stressful and more enjoyable, as drivers in the segment can now rely on the award-winning safety, connectivity and infotainment technologies known from Volvo’s acclaimed new 90- and 60 Series cars.
“The XC40 is our first car in this rapidly growing segment and has a clear focus on navigating today’s hectic city environments. Building on Volvo’s heritage as the leader in safety, the new XC40 will offer the best possible safety standards combined with an easy-to-use interface and convenient connected services,” said Håkan Samuelsson, president and chief executive.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8170551-volvo-cars-xc40-suv-designed-city-living/
Today LeapFrog® Enterprises, Inc., the leader in innovative learning toys for children, announced the availability of its successful infant and preschool toy collection. These new products join an extensive range of toys that actively teach important early learning skills, such as counting, shapes, colors and the alphabet, while introducing the problem-solving, creativity and social skills children will need to thrive as they grow.
“LeapFrog understands the importance of fostering fun learning experiences that empower and inspire children to leap ahead,” said William To, President, VTech Electronics North America. “We believe the new introductions reflect the high-quality learning products children love and parents have come to expect from LeapFrog.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8140754-leapfrog-infant-preschool-learning-toys/
Kiehl’s Since 1851, the 166-year-old skincare company, has used its fleet of iconic motorcycles to raise funds and awareness for AIDS research and awareness for the eighth year in a row. Kiehl’s LifeRide for amfAR, a charitable motorcycle ride from Minneapolis to Nashville, July 31 to Aug. 7, has already raised more than $125,000 for amfAR, The Foundation for AIDS Research and fundraising will continue through August.
Kiehl’s President Chris Salgardo and amfAR CEO Kevin Robert Frost led the 1,200 mile, 8-day journey, accompanied by actors Tyler Posey, Gilles Marini and Ian Bohen, tattoo artist Luke Wessman, and TV hosts Anthony Carrino and Grant Reynolds. Over eight days, the riders participated in nine public events, meeting customers and educating about HIV/AIDS research.
To view the multimedia release go to:
https://www.multivu.com/players/English/8160451-kiehls-liferide-for-amfar-aids-research-liferide8/
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Academy Award winner Oliver Stone secured what journalists, news organizations, and even other world leaders have long coveted: extended, unprecedented access to Russian President Vladimir Putin. The day after Showtime® completed the broadcast of its four-part documentary, a series of interviews between iconic filmmaker Oliver Stone and Russian President Vladimir Putin, Hot Books, a division of Skyhorse Publishing, has published The Putin Interviews: Oliver Stone Interviews Vladimir Putin, the complete transcript of the original interviews, containing additional content not included in the Showtime series.
To view the multimedia release go to:
https://www.multivu.com/players/English/8121751-hot-books-oliver-stone-the-putin-interviews/
Volvo Cars, the premium carmaker, has announced a close partnership with Google, one of the world’s largest technology companies, to develop the next generation of its award-winning in-car infotainment and connectivity solution based on Android, offering access to a wide array of apps and services. It will launch on new Volvo models within two years.
The partnership promises to revolutionise how Volvo customers engage and interact with their cars. The large catalogue of popular Android apps – developed by Google, Volvo, or third party app developers – will offer connected and predictive services in and around the car.
“We are making an important strategic step with the Google partnership. Google’s platform and services will enhance the user experience by enabling more personalisation possibilities, while Android will offer increased flexibility from a development perspective,” said Henrik Green, Senior Vice President Research & Development at Volvo Car Group.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8103651-volvo-cars-google-android-connected/
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients.
“The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
At just nine miles wide and a marathon-run long (or 26 miles), roughly 16,000 people call Martha’s Vineyard home, but the population swells to 100,000 during the busiest summer months. On this island south of Cape Cod, local organizations like South Mountain Company – an integrated architecture, building, engineering, and renewable energy company – know that thoughtful, responsible use of natural and human resources is key to maintaining the island’s vitality and beauty.
“South Mountain Company is a worker cooperative which means our employees have an ownership stake in the business, giving them the means to make lasting, valuable change where we all live and work – and installing SunPower solar is one way we choose to make an impact,” said John Abrams, founder, CEO and president of South Mountain Company. “We believe that every property South Mountain Company designs and builds should be both attractive and low-impact, producing more energy than it consumes whenever possible.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7706156-sunpower-south-mountain-marthas-vineyard/
Judicial Crisis Network reports the follow update regarding the nomination process of Judge Neil M. Gorsuch to the high court:
Leonard Leo, an adviser to President Donald J. Trump on the Supreme Court, said today the President’s high court nominee, Judge Neil M. Gorsuch, will be confirmed by the end of the week despite the gridlock strategy being employed by Senate Democrats.
To view the multimedia release go to:
https://www.multivu.com/players/English/8077151-judge-neil-gorsuch-supreme-court-nomination/
Volvo Cars, the premium car maker, today revealed the long-awaited new XC60 premium SUV at the Geneva Motor Show.
The new car replaces Volvo’s highly-successful original XC60, which in the nine years since its launch became the bestselling premium mid-sized SUV in Europe with nearly a million units sold globally. The XC60 today represents around 30 per cent of Volvo’s total global sales.
“We have a strong heritage in designing stylish and dynamic SUVs that offer the latest in technology. The new XC60 will be no exception. It’s the perfect car for an active lifestyle, and it represents the next step in our transformation plan,” said Håkan Samuelsson, President and Chief Executive, Volvo Car Group.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8054851-volvo-cars-reveals-new-xc60-premium-suv/
